학술논문

RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease
Document Type
Article
Source
In: Journal of Molecular and Cellular Cardiology. (Journal of Molecular and Cellular Cardiology, August 2023, 181:67-78)
Subject
Language
English
ISSN
10958584
00222828